ArticleHeliyon2024

Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of ALI/ARDS patients with COVID-19.

Ruiying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.